Literature DB >> 1612355

Towards a relatively inexpensive, noninvasive, accurate test for colonic motility disorders.

M Camilleri1, A R Zinsmeister.   

Abstract

Currently available clinical tests of colonic transit, such as the radiopaque marker method, are useful to detect delayed transit but may be less sensitive for rapid transit. The aim of this study was to develop a relatively inexpensive, noninvasive, accurate test of colonic transit using selected scintigraphic observations within the first 24 hours after ingestion of a pH-sensitive, methacrylate-coated, delayed-release capsule containing 111In-labeled resin pellets. The authors' previously published colonic transit data on 22 healthy subjects, 9 patients with diarrhea-predominant irritable bowel syndrome, and 7 patients with idiopathic constipation and previously unpublished data on 4 patients with carcinoid diarrhea were analyzed. A logistic discriminant analysis was used to estimate the sensitivity and specificity of selected combinations or simple summaries of transit. Among combined transit summaries, the emptying rate of the proximal colon was significantly different between healthy and constipation groups; the geometric center of isotope in the colon at 4 hours was significantly greater in the diarrhea group than in healthy controls; the geometric center at 24 hours was significantly lower in the constipation group than in the other two groups. From the logistic discriminant analysis, simple summaries of transit also had significant discriminant value; these included the isotopic contents in the ascending, transverse, and descending colon at 4 hours and the counts in the ascending and transverse colon and stool at 24 hours. At 90% sensitivity, the specificity of the transverse colon counts at 4 hours was 79%, which is identical to the specificity of the proximal colon emptying rate, both adjusted for age. Thus, quantitation of isotopic counts in colonic regions on scans taken at 4 and 24 hours provides an accurate summary of colonic transit, with acceptable specificity at a high sensitivity in the detection of motility disorders of the colon.

Entities:  

Mesh:

Year:  1992        PMID: 1612355     DOI: 10.1016/0016-5085(92)91092-i

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  31 in total

Review 1.  Methods for the assessment of small-bowel and colonic transit.

Authors:  Lawrence A Szarka; Michael Camilleri
Journal:  Semin Nucl Med       Date:  2012-03       Impact factor: 4.446

Review 2.  Measurement of gastrointestinal transit.

Authors:  Henry C Lin; Charlene Prather; Robert S Fisher; James H Meyer; Robert W Summers; Mark Pimentel; Richard W McCallum; Louis M A Akkermans; Vera Loening-Baucke
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

3.  HLA-DQ genotype is associated with accelerated small bowel transit in patients with diarrhea-predominant irritable bowel syndrome.

Authors:  Maria I Vazquez-Roque; Michael Camilleri; Paula Carlson; Sanna McKinzie; Joseph A Murray; Tricia L Brantner; Duane D Burton; Alan R Zinsmeister
Journal:  Eur J Gastroenterol Hepatol       Date:  2011-06       Impact factor: 2.566

4.  Effects of naloxegol on whole gut transit in opioid-naïve healthy subjects receiving codeine: A randomized, controlled trial.

Authors:  H Halawi; P Vijayvargiya; I Busciglio; I Oduyebo; D Khemani; M Ryks; D Rhoten; D Burton; L A Szarka; A Acosta; M Camilleri
Journal:  Neurogastroenterol Motil       Date:  2018-02-06       Impact factor: 3.598

5.  Prevalence of colonic motor or evacuation disorders in patients presenting with chronic nausea and vomiting evaluated by a single gastroenterologist in a tertiary referral practice.

Authors:  G J Kolar; M Camilleri; D Burton; A Nadeau; A R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2013-10-10       Impact factor: 3.598

6.  Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans.

Authors:  E P Bouras; M Camilleri; D D Burton; S McKinzie
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

7.  Regional colon transit in patients with dys-synergic defaecation or slow transit in patients with constipation.

Authors:  Sara Nullens; Tyler Nelsen; Michael Camilleri; Duane Burton; Deborah Eckert; Johanna Iturrino; Maria Vazquez-Roque; Alan R Zinsmeister
Journal:  Gut       Date:  2011-12-16       Impact factor: 23.059

8.  Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome.

Authors:  Michael Camilleri; Sanna McKinzie; Irene Busciglio; Phillip A Low; Seth Sweetser; Duane Burton; Kari Baxter; Michael Ryks; Alan R Zinsmeister
Journal:  Clin Gastroenterol Hepatol       Date:  2008-05-05       Impact factor: 11.382

9.  Pilot study of pathophysiology of constipation among community diabetics.

Authors:  D Maleki; M Camilleri; D D Burton; D M Rath-Harvey; L Oenning; J H Pemberton; P A Low
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

10.  Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation.

Authors:  M L Manini; M Camilleri; M Goldberg; S Sweetser; S McKinzie; D Burton; S Wong; M M Kitt; Y-P Li; A R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2009-08-18       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.